Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:00 PM
Ignite Modification Date:
2025-12-25 @ 8:29 PM
NCT ID:
NCT01067469
Group ID:
EG001
Title:
Low Dose Bevacizumab + Lomustine
Description:
Bevacizumab 5 mg/kg IV over 90 minutes on Day 1 and 22 (every 3 weeks) of 6 week cycle. Lomustine starting dose of 90 mg/m2 administered orally at sleep time on Day 3 of every 6 week cycle. Due to hematologic toxicities, the starting dose was reduced to 75 mg/m2.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
35
Other Number Affected:
23
Other Number At Risk:
35
Study:
NCT01067469
Results Section:
NCT01067469
Adverse Events Module:
NCT01067469